On Thursday, Shares of Pfizer Inc. (NYSE:PFE), lost -1.81% to $35.17.
Pfizer declared that the European Commission (EC) has approved under the European Union (EU) Merger Regulation the company’s pending acquisition of Hospira, Inc. (HSP). The Commission’s decision comprises Pfizer’s commitment to divest certain assets.
“We are happy to have achieved a noteworthy milestone for Pfizer’s pending acquisition of Hospira with the EC’s approval of the transaction,” said Ian Read, chairman and chief executive officer, Pfizer. “We continue to work cooperatively with the regulatory agencies to obtain the requisite approvals, and continue to expect the transaction to close in the second half of 2015.”
Completion of the transaction remains subject to the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, governmental and regulatory approvals in certain other jurisdictions and other usual and customary closing conditions.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
Shares of Nokia Corporation (NYSE:NOK), declined -0.58% to $6.81, during its last trading session.
Based on Nokia Corporation’s 2011 Stock Option Plan a total of 23 908 Nokia shares were subscribed for between June 30 and August 3, 2015. The subscription price was EUR 5.76 per share for 8 908 shares and EUR 2.18 per share for 15 000 shares. The total amount of the subscription price, EUR 84 010.08, will be recorded in the fund for invested non-restricted equity and, consequently, the share capital of the company does not enhance.
The total amount of Nokia shares after registration of the shares with the Trade Register is 3 678 362 141 shares. The new shares carry all the shareholder rights as of the registration date August 7, 2015. The shares are subject to trading on Nasdaq Helsinki together with other Nokia shares (NOK1V) as of August 7, 2015. As declared on August 5, 2015 Nokia is changing its stock symbol (trading code) on Nasdaq Helsinki from NOK1V to NOKIA, effective at the start of trading on Monday, August 10, 2015.
Nokia Corporation, together with its auxiliaries, provides network infrastructure and related services in Finland, the United States, Japan, China, India, the Russian Federation, Germany, Taiwan, Indonesia, Italy, and internationally. The company operates through four segments: Mobile Broadband, Global Services, HERE, and Nokia Technologies.
Finally, Herbalife Ltd. (NYSE:HLF), ended its last trade with 17.23% surge, and closed at $57.56, hitting its highest level.
Herbalife stated second quarter net sales of $1.2 billion. Local currency net sales grew by 1%, while stated net sales declined 11% primarily due to the ongoing unfavorable impact of currency exchange rates. Adjusted earnings for the quarter were $1.24 per diluted share contrast to $1.55 per diluted share for the same period in 2014. On a stated basis, second quarter net income was $82.8 million, or $0.97 per diluted share, contrast to $119.5 million, or $1.31 per diluted share for the same period in 2014. Second quarter 2015 diluted EPS was negatively influenced by a $0.412 currency fluctuation.
For the quarter ended June 30, 2015, the company generated $197.6 million in net operating cash flow, and invested $16.2 million in capital expenditures.
The company is raising its adjusted diluted EPS guidance for the year to a range of $4.50 to $4.70, from the previous range of $4.30 to $4.60.
Herbalife Ltd., a nutrition company, develops and sells weight administration, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, and personal care products. The company offers science-based products in four principal categories, counting weight administration; targeted nutrition; energy, sports, and fitness; and outer nutrition.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
